Rhenman & Partners Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$5.38M	Buy
2025 Q1	$5.32M	Buy
2024 Q4	$3.07M	Sell
2024 Q3	$5M	Buy
2024 Q2	$4.69M	Buy
2024 Q1	$4.25M	Buy